B A C K G R O U N D
Upper tract transitional cell carcinoma (TCC) arises from the renal pelvis, calices and ureters. These tumours are uncommon and constitute only 5% of TCCs of the entire renal tract (Campbell-Wash 2003) . TCCs of the renal pelvis account for 10% of all renal tumours and ureteric TCCs are even less common (El-Fettouh 2002). Bilateral disease is extremely rare and occurs in 2% to 4% of the cases (Browne 2005) . Although histologically similar to bladder TCCs, upper tract transitional cell carcinoma is more aggressive tumours with a tendency to multifocality, local recurrence and progression to an advanced stage ( Open nephroureterectomy (ONU) has been the standard surgical option for upper-tract TCCs with a normally functioning contralateral collecting system. The procedure itself consists of total nephrouretectomy with excision of the bladder cuff around the ureteric orifices to prevent tumour recurrence in the ureteric stump or around the ipsilateral ureteric orifice. The procedure entails either two long incisions or single long incisions for adequate exposure. As a result there is significant morbidity in the form postoperative pain and therefore prolonged hospitalisation (Rassweiler 2004).
There has been considerable advancement in minimal invasive surgery in recent years to counter issues of post-operative pain, prolonged hospitalisation associated with ONU. Some of the viable options include laparoscopic nephroureterectomy (LNU), ureteroscopic resection/fulgaration or percutaneous management. 
O B J E C T I V E S
To determine the best surgical management of upper tract transitional cell carcinoma.
The following comparisons are pre-stated:
1.Whether open radical nephroureterectomy is better than laparoscopic nephroureterectomy 2.Whether nephroureterectomy is better than conservative localised resection of ureter, where indicated 
Criteria for considering studies for this review

Types of studies
All randomised or quasi-randomised controlled trials comparing the various surgical methods and approaches for the management of localised upper tract transitional cell carcinoma.
Types of participants
All adult patients with localised transitional cell carcinoma. Localised disease is defined as limited to the kidney or ureter with no gross lymph nodal enlargement on imaging.
Types of interventions
Any surgical method or approach for managing localised renal cell carcinoma.
Types of outcome measures
Various outcomes of interest are: EARLY SURGICAL OUTCOME Need for re-operation Operative complications Post-operative morbidity / mortality Length of operation Length of hospital stay Duration of catheterization Analgesic requirement Positive surgical margins (local resection of ureter) CANCER OUTCOME MEASURES Overall survival Cancer-specific survival Positive margin rate Incidence of local recurrence or progression Incidence of distant metastasis HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUT-COME MEASURES Generic HRQOL measures (e.g. SF-36 Ware 1992) Disease-specific HRQOL measures (e.g. UCLA PCI Litwin 1998) HEALTH ECONOMIC OUTCOME MEASURES Resource implications of differences in outcomes Resource implications of differences in impact on HRQOL Formal economic analysis (cost utility) Length of hospital stay (days) and associated costs (in GBP)
Search methods for identification of studies
A sensitive search strategy will be devloped to identify relevant studies for inclusion in this review . The following search terms will
